Heni Drugs Pvt Ltd, a active private limited company, was established on 15 February 1993 in Mumbai, Maharashtra, India. Engaging in industrial chemicals within the manufacturing sector, it holds CIN: U24139MH1993PTC070791. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.12 M.
It upholds a compliant status. Employing 23 professional, Its leadership includes Kapil Satyabhusan Girotra (Director), Devika Hemendra Thakrar (Director), Nisha Hemendra Thakrar (Director). Past directors included Nicole Hemendra Thakrar, Hemendra Kalidas Thakrar. It holds ₹6.62 Cr open charges and ₹6.97 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 26 Dream Land Vikramnear Shastri Nagar Mulund Colony, Mumbai, Maharashtra, 400082.
U24139MH1993PTC070791
070791
15 February 1993
₹0.20 M
₹0.12 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Heni Drugs Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kapil Satyabhusan Girotra | Director | 22 Apr 2014 | Current |
| Devika Hemendra Thakrar | Director | 01 Apr 2008 | Current |
| Nisha Hemendra Thakrar | Director | 15 Feb 1993 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 12 Feb 2018 | Past |
| Pramod Abcsdd | Director | 04 Jul 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Heni Drugs Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 27.17% increase. The company also saw a substantial improvement in profitability, with a 29.74% increase in profit. The company's net worth Soared by an impressive increase of 19.74%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Heni Drugs had a public holding of 47.05%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹66,211,964.00
₹69,700,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Sep 2018 | Others | ₹0.62 M | Open |
| 28 Aug 2017 | Others | ₹6.56 Cr | Open |
| 23 Jan 2023 | State Bank Of India | ₹4.95 Cr | Satisfied |
| 29 Jun 2015 | Citi Bank N.A. | ₹2.00 Cr | Satisfied |
| 25 Jul 2000 | The Thane Janata Sahakari Bank Ltd | ₹0.20 M | Satisfied |
Explore comprehensive loan charge details -
Heni Drugs has a workforce of 23 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Heni Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Heni Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others of Rs. 65.59 M registered on 28 Aug 2017 with Charge ID 100122556 was modified on 11 Aug 2025. was documented.
The activity A charge registered on 23 Jan 2023 via Charge ID 100682346 with State Bank Of India was fully satisfied on 20 Jan 2025. was completed.
The activity Heni Drugs Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Heni Drugs Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
The activity A charge registered on 29 Jun 2015 via Charge ID 10627983 with Citi Bank N.A. was fully satisfied on 01 Nov 2023. was completed.
A charge with State Bank Of India amounted to Rs. 49.50 M with Charge ID 100682346 was registered on 23 Jan 2023. was recorded as a recent event.
The CIN of Heni Drugs Pvt Ltd is U24139MH1993PTC070791.
Heni Drugs Pvt Ltd is headquartered at 26 Dream Land Vikramnear Shastri Nagar Mulund Colony, Mumbai, Maharashtra, 400082.
Heni Drugs Pvt Ltd was incorporated on 15 February 1993.
The current directors of Heni Drugs Pvt Ltd are
The primary industry of Heni Drugs Pvt Ltd is Manufacturing.
Heni Drugs Pvt Ltd is unlisted.
The authorized capital of Heni Drugs Pvt Ltd is ₹0.20 M, and the paid-up capital is ₹0.12 M.
The compliance status of Heni Drugs Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX